OrbiMed Capital GP VII, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $12,259,936.44
Shares · price: 272,322 sh · $45.02 a share
Held after: 7,388,902 sh
Stock: Enliven Therapeutics ELVN
Person: OrbiMed Capital GP VII10% Owner
Trade date: 26/06/15
Filed: 26/06/17
Days to filing: 2 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 05/16~07/15

OrbiMed Capital GP VII's recent trades

OrbiMed Capital GP VIIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
OrbiMed Capital GP VIIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
OrbiMed Capital GP VIIDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
OrbiMed Capital GP VIIDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
OrbiMed Capital GP VIIDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21